Cargando…

microRNA‐1914, which is regulated by lncRNA DUXAP10, inhibits cell proliferation by targeting the GPR39‐mediated PI3K/AKT/mTOR pathway in HCC

Increasing studies have confirmed that abnormally expressed microRNAs (miRNAs) take part in the carcinogenesis as well as the aggravation of hepatocellular carcinoma (HCC). However, little information is currently available about miR‐1914 in HCC. Here, we first confirmed that miR‐1914 inhibition in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Liankang, Wang, Liang, Chen, Tianxiang, Yao, Bowen, Wang, Yufeng, Li, Qing, Yang, Wei, Liu, Zhikui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850956/ https://www.ncbi.nlm.nih.gov/pubmed/31576658 http://dx.doi.org/10.1111/jcmm.14705

Ejemplares similares

LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells
por: Sun, Liankang, et al.
Publicado: (2020)

lncRNA DUXAP8 Facilitates Multiple Malignant Phenotypes and Resistance to PARP Inhibitor in HCC via Upregulating FOXM1
por: Hu, Yu, et al.
Publicado: (2020)

Long noncoding RNA PICSAR/miR‐588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway
por: Liu, Zhikui, et al.
Publicado: (2020)

LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathway
por: Lei, Changjiang, et al.
Publicado: (2022)

The LncRNA DUXAP10 Could Function as a Promising Oncogene in Human Cancer
por: Zhao, Junjie, et al.
Publicado: (2022)

Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma
por: Liu, Zhikui, et al.
Publicado: (2019)

Retraction Note: Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma
por: Liu, Zhikui, et al.
Publicado: (2022)

Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt/β-catenin signal pathway in hepatocellular carcinoma
por: Wang, Yufeng, et al.
Publicado: (2018)

Correction: Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt/β-catenin signal pathway in hepatocellular carcinoma
por: Wang, Yufeng, et al.
Publicado: (2022)

MicroRNA-875-5p inhibits tumor growth and metastasis of hepatocellular carcinoma by targeting eukaryotic translation initiation factor 3 subunit a
por: Chen, Tianxiang, et al.
Publicado: (2020)

LncRNA DUXAP8 as a prognostic biomarker for various cancers: A meta-analysis and bioinformatics analysis
por: Wang, Yongfeng, et al.
Publicado: (2022)

Downregulated DUXAP8 lncRNA impedes trophoblast cell proliferation and migration by epigenetically upregulating TFPI2 expression
por: Tang, Xiaotong, et al.
Publicado: (2023)

The Coordination of mTOR Signaling and Non-Coding RNA in Regulating Epileptic Neuroinflammation
por: Zeng, Chudai, et al.
Publicado: (2022)

A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR
por: Song, Runjie, et al.
Publicado: (2023)

Silencing lncRNA DUXAP8 inhibits lung adenocarcinoma progression by targeting miR-26b-5p
por: Liu, Yi, et al.
Publicado: (2021)

The cancer-testis lncRNA LINC01977 promotes HCC progression by interacting with RBM39 to prevent Notch2 ubiquitination
por: Xia, Anliang, et al.
Publicado: (2023)

miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418
por: Wang, Liang, et al.
Publicado: (2019)

miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction
por: Wang, Liang, et al.
Publicado: (2022)

MiR-4319 induced an inhibition of epithelial-mesenchymal transition and prevented cancer stemness of HCC through targeting FOXQ1
por: Han, Shaoshan, et al.
Publicado: (2019)

LncRNA-DUXAP8 Regulation of the Wnt/β-Catenin Signaling Pathway to Inhibit Glycolysis and Induced Apoptosis in Acute Myeloid Leukemia
por: Zhai, Hong, et al.
Publicado: (2021)

lncRNA TINCR promotes the development of cervical cancer via the miRNA‑7/mTOR axis in vitro
por: Liu, Xuan, et al.
Publicado: (2023)

Targeting the lncRNA DUXAP8/miR-29a/PIK3CA Network Restores Doxorubicin Chemosensitivity via PI3K-AKT-mTOR Signaling and Synergizes With Inotuzumab Ozogamicin in Chemotherapy-Resistant B-Cell Acute Lymphoblastic Leukemia
por: Zhang, Li, et al.
Publicado: (2022)

EDG2 enhanced the progression of hepatocellular carcinoma by LPA/PI3K/AKT/ mTOR signaling
por: Xu, Meng, et al.
Publicado: (2017)

DUXAP8, a pseudogene derived lncRNA, promotes growth of pancreatic carcinoma cells by epigenetically silencing CDKN1A and KLF2
por: Lian, Yifan, et al.
Publicado: (2018)

LncRNA DUXAP9‐206 directly binds with Cbl‐b to augment EGFR signaling and promotes non‐small cell lung cancer progression
por: Zhu, Ting, et al.
Publicado: (2018)

Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de‐palmitoylation
por: Shi, Zhehao, et al.
Publicado: (2023)

GPR39 deorphanization: The long and winding road to eicosanoids and a crosstalk between GPR39 and hedgehog signaling in angiogenesis
por: Doboszewska, Urszula, et al.
Publicado: (2023)

CDCA2 Promotes HCC Cells Development via AKT–mTOR Pathway
por: Li, Kai, et al.
Publicado: (2022)

Hepatocellular loss of mTOR aggravates tumor burden in nonalcoholic steatohepatitis-related HCC
por: Kroh, Andreas, et al.
Publicado: (2023)

Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers
por: Chen, Jing, et al.
Publicado: (2019)

lncRNA TINCR facilities bladder cancer progression via regulating miR-7 and mTOR
por: Xu, Guoying, et al.
Publicado: (2020)

Role of GPR39 in Neurovascular Homeostasis and Disease
por: Xu, Yifan, et al.
Publicado: (2021)

GPR41 Regulates the Proliferation of BRECs via the PIK3-AKT-mTOR Pathway
por: Meng, Zitong, et al.
Publicado: (2023)

Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP
por: Sun, Liankang, et al.
Publicado: (2019)

CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway
por: Yang, Nan, et al.
Publicado: (2020)

A novel classification of HCC basing on fatty-acid-associated lncRNA
por: Xu, Yating, et al.
Publicado: (2022)

N6-Methyladenosine Modification of LncRNA DUXAP9 Promotes Renal Cancer Cells Proliferation and Motility by Activating the PI3K/AKT Signaling Pathway
por: Tan, Lei, et al.
Publicado: (2021)

LncRNA‐DANCR contributes to lung adenocarcinoma progression by sponging miR‐496 to modulate mTOR expression
por: Lu, Qing‐chun, et al.
Publicado: (2017)

Metformin Activates the AMPK-mTOR Pathway by Modulating lncRNA TUG1 to Induce Autophagy and Inhibit Atherosclerosis
por: You, Ganhua, et al.
Publicado: (2020)

lncRNA OGFRP1 promotes tumor progression by activating the AKT/mTOR pathway in human gastric cancer
por: Zhang, Jingzhou, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f44eh2i6cnn6lddncfih79tm5s